000 01567 a2200457 4500
005 20250516121631.0
264 0 _c20131112
008 201311s 0 0 eng d
022 _a1179-2027
024 7 _a10.2165/11597280-000000000-00000
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHaywood, Philip
245 0 0 _aChemotherapy administration: modelling the costs of alternative protocols.
_h[electronic resource]
260 _bPharmacoEconomics
_cDec 2012
300 _a1173-86 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Intravenous
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAustralia
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
_xeconomics
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aDecision Making
650 0 4 _aDrug Costs
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aModels, Economic
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNew South Wales
700 1 _ade Raad, Johan
700 1 _avan Gool, Kees
700 1 _aHaas, Marion
700 1 _aGallego, Gisselle
700 1 _aPearson, Sallie-Anne
700 1 _aFaedo, Margaret
700 1 _aWard, Robyn
773 0 _tPharmacoEconomics
_gvol. 30
_gno. 12
_gp. 1173-86
856 4 0 _uhttps://doi.org/10.2165/11597280-000000000-00000
_zAvailable from publisher's website
999 _c22260873
_d22260873